» Articles » PMID: 26215638

FusionCancer: a Database of Cancer Fusion Genes Derived from RNA-seq Data

Overview
Journal Diagn Pathol
Publisher Biomed Central
Specialty Pathology
Date 2015 Jul 29
PMID 26215638
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Fusion genes are chimeric results originated from previous separate genes with aberrant functions. The resulting protein products may lead to abnormal status of expression levels, functions and action sites, which in return may cause the abnormal proliferation of cells and cancer development.

Results: With the emergence of next-generation sequencing technology, RNA-seq has spurred gene fusion discovery in various cancer types. In this work, we compiled 591 recently published RNA-seq datasets in 15 kinds of human cancer, and the gene fusion events were comprehensively identified. Based on the results, a database was developed for gene fusion in cancers (FusionCancer), with the attempt to provide a user-friendly utility for the cancer research community. A flexible query engine has been developed for the acquisition of annotated information of cancer fusion genes, which would help users to determine the chimera events leading to functional changes. FusionCancer can be accessible at the following hyperlink website: http://donglab.ecnu.edu.cn/databases/FusionCancer/

Conclusion: To the best of our knowledge, FusionCancer is the first comprehensive fusion gene database derived only from cancer RNA-seq data.

Citing Articles

PUM1-TRAF3 fusion protein activates non-canonical NF-κB signaling via rescued NIK in biliary tract cancer.

Jung D, Seo M, Jo J, Kim K, Kim C, Kang H NPJ Precis Oncol. 2024; 8(1):170.

PMID: 39090283 PMC: 11294552. DOI: 10.1038/s41698-024-00654-2.


Comparison of the classifiers based on mRNA, microRNA and lncRNA expression and DNA methylation profiles for the tumor origin detection.

Feng Y, Wang Y Front Genet. 2024; 15:1383852.

PMID: 38933920 PMC: 11199677. DOI: 10.3389/fgene.2024.1383852.


Beyond traditional translation: ncRNA derived peptides as modulators of tumor behaviors.

Wen K, Chen X, Gu J, Chen Z, Wang Z J Biomed Sci. 2024; 31(1):63.

PMID: 38877495 PMC: 11177406. DOI: 10.1186/s12929-024-01047-0.


Clinically relevant fusion oncogenes: detection and practical implications.

Sorokin M, Rabushko E, Rozenberg J, Mohammad T, Seryakov A, Sekacheva M Ther Adv Med Oncol. 2023; 14:17588359221144108.

PMID: 36601633 PMC: 9806411. DOI: 10.1177/17588359221144108.


Structural variant analysis of a cancer reference cell line sample using multiple sequencing technologies.

Talsania K, Shen T, Chen X, Jaeger E, Li Z, Chen Z Genome Biol. 2022; 23(1):255.

PMID: 36514120 PMC: 9746098. DOI: 10.1186/s13059-022-02816-6.


References
1.
. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res. 2013; 42(Database issue):D7-17. PMC: 3965057. DOI: 10.1093/nar/gkt1146. View

2.
Jia W, Qiu K, He M, Song P, Zhou Q, Zhou F . SOAPfuse: an algorithm for identifying fusion transcripts from paired-end RNA-Seq data. Genome Biol. 2013; 14(2):R12. PMC: 4054009. DOI: 10.1186/gb-2013-14-2-r12. View

3.
Iyer M, Chinnaiyan A, Maher C . ChimeraScan: a tool for identifying chimeric transcription in sequencing data. Bioinformatics. 2011; 27(20):2903-4. PMC: 3187648. DOI: 10.1093/bioinformatics/btr467. View

4.
Williams S, Hurst C, Knowles M . Oncogenic FGFR3 gene fusions in bladder cancer. Hum Mol Genet. 2012; 22(4):795-803. PMC: 3554204. DOI: 10.1093/hmg/dds486. View

5.
Ge H, Liu K, Juan T, Fang F, Newman M, Hoeck W . FusionMap: detecting fusion genes from next-generation sequencing data at base-pair resolution. Bioinformatics. 2011; 27(14):1922-8. DOI: 10.1093/bioinformatics/btr310. View